Sensei Biotherapeutics, Inc. 8-K

What Happened
Sensei Biotherapeutics, Inc. (SNSE) filed a Form 8-K on March 30, 2026 announcing that it issued a press release with its financial results for the full year ended December 31, 2025. The press release was attached to the filing as Exhibit 99.1.

Key Details

• Filing date: March 30, 2026 (Form 8-K, Item 2.02).
• Financial period covered: Full year ended December 31, 2025.
• Exhibit: Press release attached as Exhibit 99.1.
• Report signed by Christopher W. Gerry, President and General Counsel.

Why It Matters
This 8-K notifies investors that Sensei has released its full-year 2025 earnings and related financial information. Investors should review the attached press release and any subsequent SEC filings for specific metrics (revenue, net income/loss, cash position, guidance or operational updates) because those details drive valuation and near-term investor decisions. The filing itself is a formal disclosure of the company’s reported results and is the first place to check for verified earnings information.